RBRC02591 条件を付加する。<br>(1) 分与希望者は事前に佐邊　壽孝（sabe@obi.or.jp) に連絡をとり、分与に関して許可を得ること。 (2) 当該マウスを用いる論文発表に際しては、Acc. No. CDB0414K とともに当該マウスを記載すること。(3) 当該マウス用いる論文発表に際してはその由来として第一報論文 Nat. Immunol., 7, 724-731 (2006). を引用すること。(4) 発表論文を寄託者 (mutant.bdr@riken.jp) に連絡すること。 GIT2(-) (Acc. No. CDB0414K) GIT2(-) (Acc. No. CDB0414K) GIT2(-) (Acc. No. CDB0414K) TT2 [(C57BL/6NCrlj x CBA/JNCrlj)F1] (1) The RECIPIENT shall obtain a prior agreement from Dr. Hisataka SABE (sabe@obi.or.jp) to transfer the BIOLOGICAL RESOURCE. (2) In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the Accession No. CDB0414K and the BIOLOGICAL RESOURCE is requested. (3) In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the literature designed by the DEPOSITOR is requested, Nat Immunol. 2006 Jul; 7 (7): 724-31. (4) Please inform the DEPOSITOR (mutant.bdr@riken.jp) about the paper when published. B6.Cg-Git2<tm1Hsb>/SiaRbrc Immunology and Inflammation Research <a href='https://brc.riken.jp/mus/pcr02591'>Genotyping protocol -PCR-</a> C (3-6 months) RIKEN CDB RIKEN CDB E. coli Neo, Phage P1 loxP、 mouse PKG promoter, mouse PKG 3’ end C（3〜6か月） Necessary documents for ordering:<ol><li>Order form (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_4.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_b.docx">English</A>)</li><li>Category I MTA: MTA for distribution with RIKEN BRC (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_5.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_c.docx">English</A>)</li><li>Acceptance of responsibility for living modified organism (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_7.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_g.docx">English</A>)</li></ol> true